Sarra Yacoub
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sarra Yacoub has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Badreddine Sriha
Department of Pathology and Clinical Research and development Unit of pathology department, Farhat Hached University Hospital, Sousse, Tunisia
2 shared publicationsTaghrid Tlili
Department of Pathology and Clinical Research and development Unit of pathology department, Farhat Hached University Hospital, Sousse, Tunisia
2 shared publicationsWafa Mokni
Farhat Hached University Hospital Clinical Research and development Unit of pathology department, Sousse, Tunisia
2 shared publications- Badra Bannour
University of Sousse, Faculty of Medicine of Sousse, Department of Obstetrics and Gynecology , Farhat Hached University Hospital of Sousse , Sousse , Tunisia
1 shared publication - Ekram Guerbej
Department of Obstetrics and Gynecology, University of Sousse, Faculty of Medicine of Sousse, Farhat Hached Teaching Hospital, Sousse, Tunisia
1 shared publication - Hafedh Abbassi
Department of Obstetrics and Gynecology, Sousse University Faculty of Medicine, Farhat Hached Teaching Hospital, Sousse, Tunisia
1 shared publication
Latest Publications
- Open Access
- 14 July 2026
- Published by Springer Nature in Infectious Agents and Cancer
- Vol. 21 (1)
HIV-associated malignancies in Tunisia: a 30-year retrospective cohort study from a North African perspective
Background: Despite major advances in antiretroviral therapy (ART), HIV-associated malignancies remain a significant cause of morbidity and mortality in low- and middle-income countries. In Tunisia, data on AIDS-defining cancers (ADCs) and non–AIDS-defining cancers (NADCs) among people living with HIV (PLWH) remain scarce. Methods: We conducted a descriptive retrospective cohort study over a 30-year period (1994–2024) at Farhat Hached University Hospital, Sousse, Tunisia. All PLWH who developed at least one malignant neoplasm were included. Epidemiological, clinical, immunovirological, pathological, and outcome data were retrospectively collected and analyzed. Results: Among 655 PLWH followed during the study period, 25 patients with a median age of 36 years developed malignancies, representing 3.8% of all PLWH. 27 malignancies were identified with 2 patients developing 2 distinct malignancies: a Kaposi sarcoma (KS) and a Non-AIDS-defining cancer (NADC). AIDS-defining cancers (ADC) predominated (81.5%), mainly KS (44.4%) and non-Hodgkin lymphoma (33.3%), while NADCs accounted for 18.5%. Cancer and HIV diagnoses were concomitant in 56% of patients ( n = 14) and 92% of malignancies occurred within the first year following HIV diagnosis. Most patients presented with advanced immunodeficiency, with median CD4 counts at tumor diagnosis of 73 cells/mm³ for ADCs and 57 cells/mm³ for NADCs. Median overall survival was 1.9 years for ADCs and 3.7 years for NADCs. Conclusions: In this North African cohort, HIV-associated malignancies were predominantly AIDS-defining cancer and affected young adults with advanced immunosuppression, reflecting late HIV diagnosis for PLWH developing malignancies. Beyond strengthening early HIV testing and timely ART initiation, targeted patient education focusing on high-risk behaviors, along with efforts to reduce HIV-related stigma, are essential components to improve cancer prevention, early diagnosis, and outcomes among PLWH in resource-limited settings.
- 14 July 2026
- Published by Springer Nature in Infectious Agents and Cancer
- Vol. 21 (1)
Open AccessHIV-associated malignancies in Tunisia: a 30-year retrospective cohort study from a North African perspective
Background: Despite major advances in antiretroviral therapy (ART), HIV-associated malignancies remain a significant cause of morbidity and mortality in low- and middle-income countries. In Tunisia, data on AIDS-defining cancers (ADCs) and non–AIDS-defining cancers (NADCs) among people living with HIV (PLWH) remain scarce. Methods: We conducted a descriptive retrospective cohort study over a 30-year period (1994–2024) at Farhat Hached University Hospital, Sousse, Tunisia. All PLWH who developed at least one malignant neoplasm were included. Epidemiological, clinical, immunovirological, pathological, and outcome data were retrospectively collected and analyzed. Results: Among 655 PLWH followed during the study period, 25 patients with a median age of 36 years developed malignancies, representing 3.8% of all PLWH. 27 malignancies were identified with 2 patients developing 2 distinct malignancies: a Kaposi sarcoma (KS) and a Non-AIDS-defining cancer (NADC). AIDS-defining cancers (ADC) predominated (81.5%), mainly KS (44.4%) and non-Hodgkin lymphoma (33.3%), while NADCs accounted for 18.5%. Cancer and HIV diagnoses were concomitant in 56% of patients ( n = 14) and 92% of malignancies occurred within the first year following HIV diagnosis. Most patients presented with advanced immunodeficiency, with median CD4 counts at tumor diagnosis of 73 cells/mm³ for ADCs and 57 cells/mm³ for NADCs. Median overall survival was 1.9 years for ADCs and 3.7 years for NADCs. Conclusions: In this North African cohort, HIV-associated malignancies were predominantly AIDS-defining cancer and affected young adults with advanced immunosuppression, reflecting late HIV diagnosis for PLWH developing malignancies. Beyond strengthening early HIV testing and timely ART initiation, targeted patient education focusing on high-risk behaviors, along with efforts to reduce HIV-related stigma, are essential components to improve cancer prevention, early diagnosis, and outcomes among PLWH in resource-limited settings.
- 24 June 2026
- Published by Springer Nature in Virchows Archiv
- p. 1-7
Gallbladder MiNEN arising in association with an intracholecystic papillary neoplasm exhibiting divergent p53 expression
Mixed neuroendocrine–non-neuroendocrine neoplasms (MiNENs) of the biliary tract are exceptionally rare and predominantly involve the gallbladder (GB). Their reported association with precursor epithelial lesions raises important questions regarding histogenesis. We report the case of a 74-year-old woman who underwent cholecystectomy for calculus-associated carcinoma. Histological examination revealed a heterogeneous neoplasm composed of three intimately admixed components: an intracholecystic papillary neoplasm (ICPN), a large cell neuroendocrine carcinoma (LCNEC), and a pancreatobiliary-type adenocarcinoma. Both the ICPN and adenocarcinoma components exhibited aberrant p53 immunostaining, whereas the LCNEC showed a wild-type pattern. All components were mismatch repair proficient and demonstrated membranous β-catenin expression. In line with previous reports, this case further suggests that ICPN may represent a common precursor lesion with the potential for divergent differentiation to GB MiNEN. The discordant p53 profiles observed across tumor components may be further explained by clonal evolution and intratumoral heterogeneity.
- 24 June 2026
- Published by Springer Nature in Virchows Archiv
- p. 1-7
Gallbladder MiNEN arising in association with an intracholecystic papillary neoplasm exhibiting divergent p53 expression
Mixed neuroendocrine–non-neuroendocrine neoplasms (MiNENs) of the biliary tract are exceptionally rare and predominantly involve the gallbladder (GB). Their reported association with precursor epithelial lesions raises important questions regarding histogenesis. We report the case of a 74-year-old woman who underwent cholecystectomy for calculus-associated carcinoma. Histological examination revealed a heterogeneous neoplasm composed of three intimately admixed components: an intracholecystic papillary neoplasm (ICPN), a large cell neuroendocrine carcinoma (LCNEC), and a pancreatobiliary-type adenocarcinoma. Both the ICPN and adenocarcinoma components exhibited aberrant p53 immunostaining, whereas the LCNEC showed a wild-type pattern. All components were mismatch repair proficient and demonstrated membranous β-catenin expression. In line with previous reports, this case further suggests that ICPN may represent a common precursor lesion with the potential for divergent differentiation to GB MiNEN. The discordant p53 profiles observed across tumor components may be further explained by clonal evolution and intratumoral heterogeneity.
- Open Access
- 17 December 2025
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 19 (1) , 636
Collision tumor: a parathyroid adenoma unveiling subclinical widespread breast carcinoma: a case report
Collision tumors are rare but well-documented phenomena, where two distinct tumors of different origins are found together. We present a unique case of a p
- 17 December 2025
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 19 (1) , 636
Open AccessCollision tumor: a parathyroid adenoma unveiling subclinical widespread breast carcinoma: a case report
Collision tumors are rare but well-documented phenomena, where two distinct tumors of different origins are found together. We present a unique case of a p
- Open Access
- 2 January 2025
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 21 (1) , 85-89
From Plasmacytoma to Rib Tuberculosis: The Case of A Breast Mass With An Unexpected Diagnosis
From Plasmacytoma to Rib Tuberculosis: The Case of A Breast Mass With An Unexpected Diagnosis - European Journal of Breast Health
- 2 January 2025
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 21 (1) , 85-89
Open AccessFrom Plasmacytoma to Rib Tuberculosis: The Case of A Breast Mass With An Unexpected Diagnosis
From Plasmacytoma to Rib Tuberculosis: The Case of A Breast Mass With An Unexpected Diagnosis - European Journal of Breast Health